药物游离浓度及血浆蛋白结合率测定的最新进展:分析方法
Recent advances in the determination of unbound concentration and plasma protein binding of drugs: Analytical methods.
作者信息
Seyfinejad Behrouz, Ozkan Sibel A, Jouyban Abolghasem
机构信息
Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, 06100, Ankara, Turkey.
出版信息
Talanta. 2021 Apr 1;225:122052. doi: 10.1016/j.talanta.2020.122052. Epub 2020 Dec 27.
Drugs in the bloodstream are available in both free and bound forms in which the free drug is responsible for pharmacological activities. Since protein binding determines the amount of free concentration of the drug in the blood, determining the protein binding in the early stages of drug discovery and development is of great importance. Besides, it is most beneficial to measure the free concentration of a drug in personalized medicine and therapeutic drug monitoring. For this reason, the need for sensitive, selective, and fast analytical methods to measure the free concentration of drugs and their protein binding has increased. This review aims to summarize recent advancements in analytical approaches used for the determination of free drug concentration and plasma protein binding and will focus on the most important approaches used to determine plasma protein binding. Furthermore, the concepts of each method will be described and discussed, along with their inherent advantages and disadvantages.
血液中的药物以游离和结合两种形式存在,其中游离药物具有药理活性。由于蛋白质结合决定了血液中药物的游离浓度,在药物研发的早期阶段确定蛋白质结合情况非常重要。此外,在个性化医疗和治疗药物监测中测量药物的游离浓度最为有益。因此,对用于测量药物游离浓度及其蛋白质结合的灵敏、选择性和快速分析方法的需求增加了。本综述旨在总结用于测定游离药物浓度和血浆蛋白结合的分析方法的最新进展,并将重点关注用于测定血浆蛋白结合的最重要方法。此外,将描述和讨论每种方法的概念,以及它们固有的优缺点。